The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice

Psychoneuroendocrinology

Volumn 25, Issue 8, 2000, Pages 785-797

  Kubera, Marta ^a   Holan, Vladimir ^b   Mathison, Ronald ^c   Maes, Michael ^d,e  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^c UNIVERSITY OF CALGARY   (Canada)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e Clinical Research Center for Mental Health of Antwerp   (Belgium)

Author keywords

Amitriptyline; Cytokines; Depression; Desipramine; Immunity; Interleukin 10

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; INTERLEUKIN 1; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNITY; IMMUNOREACTIVITY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; THYMOCYTE;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CELL DIVISION; CYTOKINES; DESIPRAMINE; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; SPLEEN;

EID: 0033846763     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(00)00026-3     Document Type: Article

References (48)

1. Andreoli A.V., Keller S.E., Rabaeus M., Marin P., Bartlett J.A., Taban C. Depression and immunity: age, severity, and clinical course. Brain Behav. Immun. 7:1993;279-292.
2. Audus K.L., Gordon M.A. Characteristic of tricyclic antidepressant binding sites associated with murine lymphocytes from spleen. J. Immunopharmacol. 4:1982;1-12.
3. Audus K.L., Gordon M.A. Tricyclic antidepressant effect on the murine lymphocyte mitogen response. J. Immunopharmacol. 4:1982;13-26.
4. Auster R. Sertraline: a new antidepressant. Am. Fam. Physician. 48:1993;311-314.
5. Azpiroz A., Fano E., Garmendia L., Arregi A., Cacho R., Beitia G., Brain P.F. Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferative response, serum corticosterone level and brain norepinephrine content in male mice. Psychoneuroendocrinology. 24:1999;345-361.
6. Bellinger D.L., Felten S.Y., Felten L.D. Neural-immuneinteractions. Tasman A., Riba M. Reviews in Psychiatry. 1991;127-144 American Psychiatry Press Inc, Washington (DC).
7. Benbernou N., Esnault S., Shin H.C.K., Fekkar H., Guenounou M. Differential regulation of IFN-γ, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology. 91:1997;361-368.
8. Bluthé R.M., Crestani F., Kelley K.W., Dantzer R. Mechanisms of the behavioral effects of interleukin 1. Ann. NY Acad. Sci. 650:1992;268-275.
9. Bluthé R.M., Castanon N., Pousset F., Bristow A., Ball C., Lestage J., Michaud B., Kelley K.W., Dantzer R. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology. 24:1999;301-311.
10. Brakenhoff H., De Groot E., Evan R., Pannekoev H., Aarden L. Molecular cloning and exoression of hybridoma growth factor in Escherichia coli. J. Immunology. 139:1987;4116-4121.
11. Connor T.J., Kelly J.P., Leonard B.E. The effect of acute desipramine treatment on immunological parameters in the rat. Med. Sci. Res. 25:1997;209-211.
12. Connor T.J., Kelly J.P., Leonard B.E. Forced swim test - induced endocrine and immune changes in the rat: effect of subacute desipramine treatment. Pharmacol. Biochem. Behav. 59:1998;171-177.
13. Daniel W., Melzacka M. A comparative study on desipramine pharmacokinetics in the rat brain after administration of desipramine or of imipramine. J. Pharm. Pharmacol. 44:1992;429-432.
14. Dhabhar F.S. Stress-induced enhancement of cell-mediated immunity. Ann. NY Acad. Sci. 840:1998;359-372.
15. Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA. 96:1999;1059-1064.
16. Eisen J., Irwin J., Quay J., Livnat S. The effect of antidepressants on immune function in mice. Biol. Psychiatry. 26:1989;805-817.
17. Felten S.Y., Felten D.L. The innervation of lymphoid organs. Ader R., Felten D.L., Cohen N. Psychoneuroimmunology II. 1990;27-69 Academic Press, New York.
18. Ferjan, I., Erjavec, F., 1998. Imipramine inhibits histamine and serotonin secretion induced by various secretagogues. Inflamm. Res. (suppl. 1), S28-S29.
19. Friedman E.M., Irwin M.R., Nonogaki K. Neuropeptide Y inhibits in vivo specific antibody production in rats. Brain Behav. Immun. 9:1995;182-189.
20. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Riemann D., Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatr. Clin Neurosci. 247:1997;228-233.
21. Harris E.F., Fehl L.M., Shahkolahi A. Activity of murine killer cells during behavioral despair conditioning with and without imipramine treatment. J. Neuroimmunol. 16:1987;71.
22. Kubera, M., Maes, M., 2000. Serotonin-immune interactions in major depression. In: Petterson/Kordon/Christen (Eds.), Neuro-immune Interactions in Neurologic and Psychiatric Disorders. Springer-Verlag, Berlin Heidelberg, pp. 79-87.
23. Kubera M., Basta-Kaim A., Skowron-Cendrzak A., Mazur-Kolecka B., Roman A., Borycz J. Effect of repeated amitriptyline administration to mice on the T lymphocyte proliferative activity and natural killer cell cytotoxicity. Pol. J. Pharmacol. 47:1995;321-326.
24. Kubera M., Symbirtsev A., Basta-Kaim A., Borycz J., Roman A., Papp M., Claesson M. Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol. J. Pharmacol. 48:1996;503-506.
25. Kubera M., Holan V., Basta-Kaim A., Roman A., Borycz J., Shani J. Effect of desipramine on immunological parameters in mice, and their reversal by stress. Int. J. Immunopharmacol. 20:1998;429-438.
26. Kubera, M., Maes, M., Holan, V., Basta-Kaim, A., Roman, A., Shani, J., 1999. Effect of chronic treatment with desipramine on the immunoreactivity of C57BL/6 mice subjected to chronic mild stress model of depression. J. Affect. Disord. (in press).
27. Kubera, M., Kenis, G., Bosmans, E., Scharpé, S., Maes, M., 2000. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-γ and interleukin-10. Neuropsychopharmacol. (in press).
28. Leonard B.E. The comparative pharmacology of new antidepressants. J. Clin. Psychiatry. 8:1993;3-15.
29. Levin S. Vitamin C: Its molecular Biology and Medical Potential. 1976;Academic Press, London.
30. Maes M., Meltzer H.Y.M. The serotonin hypothesis of major depression. Bloom F.E., Kupger D.J. Psychopharmacology, The Fourth Generation of Progress. 1995;933-944 Raven Press, New York.
31. Maes M., Smith R., Scharpe S. The monocyte-T lymphocyte hypothesis of major depression. Psychoneuroendocrinology. 20:1995;111-116.
32. Maes M., Delanghe J., Ranjan R., Meltzer H.Y., Desnyder R., Cooreman W., Scharpe S. The acute phase protein response in schizophrenia, mania and major depression: effects of psychotropic drugs. Psychiatry Res. 66:1997;1-11.
33. Maes M., Song C., Lin A.-H., Bonaccorso S., Kenis G., De Jongh R., Bosmans E., Scharpe S. Negative immunoregulatory effects of antidepressants: inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology. 20:1999;370-379.
34. McDonald E.M., Mann A.H., Thomas H.C. Interferon as mediators of psychiatric morbidity: an investigation in a trial of recombinant α-interferon in hepatitis-B carriers. Lancet. 2:1987;1175-1179.
35. Michelson D., Misiewicz-Poltorak B., Raybourne R.B., Gold P.W., Sternberg E.M. Imipramine reduces the local inflammatory response to carrageenin. Agents Actions. 42:1994;25-28.
36. Miller A.H., Lackner C. Tricyclic antidepressants and immunity. Miller A.H. Depressive Disorders and Immunity. 1989;85-104 American Psychiatry Press, Washington (DC).
37. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferative and cytotoxic assays. J. Immunol. Meth. 65:1983;55-63.
38. Nalepa I. The effect of psychotropic drugs on the interaction of protein kinase C with second messenger system in the rat cerebral cortex. Pol. J. Pharmacol. 46:1994;1-14.
39. Rossenwasser L.J., Dinarello C.A. Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation. Cell. Immunol. 63:1981;134-142.
40. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., Kirchner H. Increased CD56+ natural killer cells and related cytokines in major depression. Clin. Immunol. Immunopathol. 78:1996;83-85.
41. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. Acad. Sci. 762:1995;474-476.
42. Smith R.S. The macrophage theory of depression. Med. Hypoth. 35:1991;298-306.
43. Song C., Kelly J., Leonard B.E. Is the state of leucocyte adhesiveness/aggregation an immune marker of stress in the olfactory bulbectomized rat? Stress Med. 9:1993;255-258.
44. Thakore J.H., Dinan T.G. Effect of fluoxetine on dexamethasone-induced growth hormone release in depression: a double-blind, placebo-controlled study. Am. J. Psychiatry. 152:1995;616-618.
45. Vetulani J. The development of our understanding of the mechanism of action of antidepressant drugs. Pol. J. Pharmacol. Pharmacy. 43:1991;322-338.
46. Wodarz N., Rupprecht R., Kornhuber J., Schmitz B., Wild K., Riederer P. Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder. J. Affect. Disord. 25:1992;31-38.
47. Xia Z., DePierre J., Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1β, and TNF-α release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology. 34:1996;27-37.
48. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 711:1996;163-174.